We have the foundational technology to develop rapid and quantitative diagnostic tests for different biomarkers using Quantum Dots. Our patented Quantum Dot technology makes our diagnostic tests ideal for immunity level detection, infectious disease management, and biomarker monitoring in both personal health and drug delivery technology.
A companion to our Quantum Dot technology is a secured, encrypted data platform. Our platform captures and organizes the data necessary to monitor biomarker trends in personal health, expedite drug development through biomarker tracking, and anonymize positive or negative results in infectious disease management.
We are partnering with several pharmaceutical companies to develop novel drug delivery systems. Through our Quantum Dot diagnostic technology and our data collection platform we can expedite new drugs with higher bioavailability of active pharmaceutical ingredients (API) and substantially reduced toxicity and side effects.